NZ526016A - Gene encoding syntaxin interacting protein - Google Patents

Gene encoding syntaxin interacting protein

Info

Publication number
NZ526016A
NZ526016A NZ526016A NZ52601699A NZ526016A NZ 526016 A NZ526016 A NZ 526016A NZ 526016 A NZ526016 A NZ 526016A NZ 52601699 A NZ52601699 A NZ 52601699A NZ 526016 A NZ526016 A NZ 526016A
Authority
NZ
New Zealand
Prior art keywords
leu
glu
ser
ala
lys
Prior art date
Application number
NZ526016A
Other languages
English (en)
Inventor
Jing Min
Jeffrey Eugene Pessin
Alan Robert Saltiel
Li-Jyun Syu
Original Assignee
Univ Iowa Res Found
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa Res Found, Warner Lambert Co filed Critical Univ Iowa Res Found
Publication of NZ526016A publication Critical patent/NZ526016A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ526016A 1998-04-20 1999-04-19 Gene encoding syntaxin interacting protein NZ526016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8245498P 1998-04-20 1998-04-20

Publications (1)

Publication Number Publication Date
NZ526016A true NZ526016A (en) 2004-10-29

Family

ID=22171326

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ526016A NZ526016A (en) 1998-04-20 1999-04-19 Gene encoding syntaxin interacting protein
NZ507640A NZ507640A (en) 1998-04-20 1999-04-19 Gene encoding syntaxin interacting protein

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ507640A NZ507640A (en) 1998-04-20 1999-04-19 Gene encoding syntaxin interacting protein

Country Status (9)

Country Link
EP (1) EP1071771A2 (fr)
JP (1) JP2002512031A (fr)
KR (1) KR20010042834A (fr)
AU (1) AU769825B2 (fr)
BR (1) BR9909732A (fr)
CA (1) CA2326623A1 (fr)
NZ (2) NZ526016A (fr)
WO (1) WO1999054465A2 (fr)
ZA (1) ZA200005845B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503756B1 (en) 2000-09-22 2003-01-07 Isis Pharmaceuticals, Inc. Antisense modulation of syntaxin 4 interacting protein expression
WO2004053103A2 (fr) * 2002-12-11 2004-06-24 University Of Massachusetts Procede d'introduction de sirna dans des adipocytes
FR2890859B1 (fr) * 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001519667A (ja) * 1997-04-10 2001-10-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌発現配列タグ（ｓＥＳＴｓ）

Also Published As

Publication number Publication date
WO1999054465A2 (fr) 1999-10-28
AU769825B2 (en) 2004-02-05
WO1999054465A9 (fr) 2000-01-27
KR20010042834A (ko) 2001-05-25
EP1071771A2 (fr) 2001-01-31
BR9909732A (pt) 2000-12-19
JP2002512031A (ja) 2002-04-23
AU3653599A (en) 1999-11-08
NZ507640A (en) 2003-12-19
ZA200005845B (en) 2002-04-19
WO1999054465A3 (fr) 2000-03-02
CA2326623A1 (fr) 1999-10-28

Similar Documents

Publication Publication Date Title
AU700915B2 (en) Lung cancer marker
JP3294575B2 (ja) Ｉｇｆ−１レセプターと相互作用するタンパク質、それをコードする遺伝子及びそれらの使用
CA2300364A1 (fr) Polypeptides de tumeur de la prostate et compositions antigenes
JP2004528810A (ja) 癌組織でディファレンシャルに発現される核酸配列
WO1995014777A1 (fr) Polypeptides fixant la p53 et polynucleotides les codant
US5717067A (en) Substrate for the epidermal growth factor receptor kinase
WO2000052173A2 (fr) Homologues de sphingosine kinase humaine clones
WO2000020450A9 (fr) Gene alpha-2/delta
NZ526016A (en) Gene encoding syntaxin interacting protein
US6680196B1 (en) Gene that is amplified and overexpressed in cancer and methods of use thereof
EP0863204B1 (fr) Cycline i humaine et gene la codant
JP2003530109A (ja) エルビンをコードする遺伝子及びその診断及び治療的使用
CA2359145A1 (fr) Proteine de voies d'exocytose et leurs procedes d'utilisation
AU2003266470A1 (en) Gene encoding syntaxin interacting protein
US6790622B2 (en) Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof
MXPA00009332A (es) Gen que codifica la proteina sintaxina interactuante
US6300473B1 (en) SLM-1: a novel Sam68-like mammalian protein
EP1135496B1 (fr) Ucp5
WO1999050408A1 (fr) Nouveau gene qui est amplifie et surexprime dans le cancer et methodes d'utilisation dudit gene
JP2002508180A (ja) ヒトｒａｄ１核酸、ポリペプチド、検定、治療方法および手段
Blanco DNA polymerase mu and uses thereof
EP1492553A2 (fr) Proteines homologues cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 et cg16750 intervenant dans la regulation de l'hemostasie energetique
JP2003061686A (ja) ヒトｍ−トモシン
JP2002101891A (ja) 細胞周期調節タンパク質

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed